Effect of Sarasvata ghrita & its nasya in management (Generalized anxiety disorder)

CLINICAL EFFICACY OF SARASVATA GHRITA & ITS NASYA IN CHITTODVEGA (GENERALIZED ANXIETY DISORDER) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077570

Enrollment

Registered

2024-12-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. patient willing to participate in the trial and sign the consent form. 2. Individuals between the age group of 18-50 years will be selected. 3. Individual having classical sign and symptom of chittodvega (Generaliosed anxiety disorde)

Exclusion criteria

Exclusion criteria: 1. Patient not willing for trial. 2. patient below the age 18years and above 50 years will be excluded. 3.Patient suffering from any other concomitant like-thyroid dysfunction, Diabetes mellitus, and heart disease. 4.Patent suffering from any other psychiatric illness.

Design outcomes

Primary

Measure	Time frame
SARASVATA GHRITA ORALLY AND ITS NASYA SHOWED CLINICALLY SIGNIFICANT EFFECT IN MANAGING CHITTODVEGA (GENERALIZED ANXIETY DISORDER)Timepoint: FIRST FOLLOW UP - AFTER 15 DAYS OF FIRST TRIAL. SECOUND FOLLOW UP-15 DAYS AFTER FIRST FOLLOW UP THIRD FOLLOW UP- 15 DAYS AFTER SECOUND FOLLOW UP	—

Secondary

Measure	Time frame
CLINICAL EFFICACY OF SARASVATA GHRITA & ITS NASYA IN CHITTODVEGA 9GENERALISED ANXIETY DISORDER)Timepoint: ASSESSMENT WILL BE DONE ON 0 DAY AND 45 DAYS.	—

Countries

India

Contacts

Public ContactSumit Kumar

Quadra Institute of Ayurveda And Hospital Roorkee

drrajnikant83@gmail.com8557076363

Outcome results